Quantcast

Latest Rhinitis Stories

2009-08-26 10:16:00

KENILWORTH, N.J., Aug.

2009-08-26 07:30:00

NAPLES, Fla., Aug. 26 /PRNewswire/ -- Most people might think of nettle as simply a common and aggressive weed that can sting and cause skin irritation.

2009-08-25 08:18:00

FT. WASHINGTON, Pa., Aug. 25 /PRNewswire/ -- The makers of ZYRTEC(R), McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., today announced the availability of two new allergy solutions to help adult and children allergy sufferers this fall allergy season.

2009-08-18 10:59:00

NEW YORK, Aug. 18 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc.

2009-08-07 05:46:00

NEW YORK, Aug. 7 /PRNewswire-Asia-FirstCall/ -- - Jingwei Capsules Treat Allergy Symptoms - - Complements Established Boke Nasal Spray Brand - - Diversifies Product Offering with Capsule Formulation - American Oriental Bioengineering, Inc.

2009-07-22 15:35:00

KENILWORTH, N.J., July 22 /PRNewswire-FirstCall/ -- Schering-Plough today announced that a New Drug Application (NDA) for a fixed-dose combination of mometasone furoate and formoterol fumarate has been filed in the United States and accepted for review by the U.S.

2009-06-22 05:00:00

Asthma and allergy sufferers have an alternative to Singulair and Zicam - The ALCAT Test WARSAW, Poland, June 22 /PRNewswire/ -- Last week the FDA knocked the wind out of asthmatics by requesting the manufacturers of Singulair, a popular leukotriene blocking asthma and allergy drug, to upgrade their warning against psychotic side effects.

2009-05-19 00:00:00

Schering-Plough Assumes Exclusive Worldwide Marketing Rights for Mometasone Furoate/Formoterol Combination for Asthma and COPD KENILWORTH, N.J., May 19 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced changes to its global collaboration with Novartis for the development and commercialization of fixed-dose combination therapies for the treatment of asthma and chronic obstructive pulmonary disease (COPD).

2009-05-13 04:00:00

OXFORD, England, May 13 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has initiated a phase II clinical development programme for its ragweed allergy therapy.

2009-05-11 02:00:00

LEEDS and LONDON, May 11 /PRNewswire/ -- - New Hayfever Relief Product Based on Acupressure Points Now Available in UK Stores & Widely Available on the Internet - With Photo Hayfever was unheard of only 200 years ago, however, it's believed that it now affects as many as 1 in 4 people in the UK.


Word of the Day
gubbings
  • The parings of haberdine; also, any kind of fragments.
The word 'gubbings' is a variant of the word 'gobbon', meaning 'a portion, gobbet.'